Patents by Inventor Wanki Kim

Wanki Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250120993
    Abstract: A method for controlling blood sugar, including administering an effective amount of Gallocatechin Gallate (GCG) and Isoquercitrin (IQC) to a subject in need thereof is disclosed. In an aspect, a composition including a complex component of Gallocatechin Gallate and Isoquercitrin can effectively inhibit gluconeogenesis in liver cells and effectively improve transport of glucose in differentiated fat cells and liver cells, thereby exhibiting excellent blood sugar control efficacy.
    Type: Application
    Filed: September 12, 2024
    Publication date: April 17, 2025
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Hyun Woo JEONG, Wanki KIM, Jong Hwa ROH
  • Publication number: 20250120940
    Abstract: A method for improving fatigue, exercise performance, or endurance, the method including administering an effective amount of Gallocatechin Gallate (GCG) and Isoquercitrin (IQC) to a subject in need thereof is disclosed. In an aspect, a composition including a complex component of Gallocatechin Gallate and Isoquercitrin can effectively inhibit accumulation of lactic acids in muscle cells and significantly increase mitochondria in the cells.
    Type: Application
    Filed: September 12, 2024
    Publication date: April 17, 2025
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Hyun Woo JEONG, Wanki KIM, Jong Hwa ROH
  • Publication number: 20250120992
    Abstract: This specification discloses a method for improving liver health, including administering an effective amount of Gallocatechin Gallate (GCG) and Isoquercitrin (IQC) to a subject in need thereof. In an aspect, a composition including a complex component of Gallocatechin Gallate and Isoquercitrin effectively reduces oxidative stress and chronic inflammatory reaction that occurs during accumulation of lipids in liver tissue, thereby making it possible to enhance liver health and prevent, improve, or treat various liver diseases such as hepatitis, cirrhosis, and liver cancer.
    Type: Application
    Filed: September 3, 2024
    Publication date: April 17, 2025
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Hyun Woo JEONG, Wanki KIM, Jong Hwa ROH
  • Patent number: 12261038
    Abstract: Provided herein are methods and apparatus for filling one or more gaps on a semiconductor substrate. The disclosed embodiments are especially useful for forming seam-free, void-free fill in both narrow and wide features. The methods may be performed without any intervening etching operations to achieve a single step deposition. In various implementations, a first operation is performed using a novel PEALD fill mechanism to fill narrow gaps and line wide gaps. A second operation may be performed using PECVD methods to continue filling the wide gaps.
    Type: Grant
    Filed: September 2, 2021
    Date of Patent: March 25, 2025
    Assignee: Lam Research Corporation
    Inventors: Hu Kang, Shankar Swaminathan, Jun Qian, Wanki Kim, Dennis M. Hausmann, Bart J. van Schravendijk, Adrien LaVoie
  • Patent number: 12250958
    Abstract: One aspect of the present disclosure is a stabilizer composition for stabilizing a liquid composition containing a collagen peptide having a tripeptide composed of Gly-Pro-Hyp, and a food having the same, and in stabilizer composition for stabilizing a liquid composition containing a collagen peptide according to one aspect of the present disclosure, the stabilizer composition contains glucono-delta-lactone as an active ingredient, a pH is 3.0 to 4.0, the GPH, an indicator ingredient of the collagen peptide, is stabilized, and there is an excellent effect of being able to easily manufacture and distribute as a food with a longer shelf life and a very high preference for the decrease in GPH content as the storage period is prolonged.
    Type: Grant
    Filed: August 22, 2022
    Date of Patent: March 18, 2025
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Changyong Moon, Minjung Kwon, Sunghwan Lim, Chanwoong Park, Wanki Kim
  • Patent number: 12185646
    Abstract: A phase change memory (PCM) structure configured for performing a gradual reset operation includes first and second electrodes and a phase change material layer disposed between the first and second electrodes. The PCM structure further includes a thermal insulation layer disposed on at least sidewalls of the first and second electrodes and phase change material layer. The thermal insulation layer is configured to provide non-uniform heating of the phase change material layer. Optionally, the thermal insulation layer may be formed as an air gap. The PCM structure may be configured having the first and second electrodes aligned in a vertical or a lateral arrangement.
    Type: Grant
    Filed: December 15, 2022
    Date of Patent: December 31, 2024
    Assignee: International Business Machines Corporation
    Inventors: Ning Li, Wanki Kim, Devendra K. Sadana
  • Publication number: 20240390320
    Abstract: Disclosed herein is a method for inhibiting lipogenesis; inhibiting fat accumulation; promoting fat breakdown; reducing body fat; and/or preventing, improving or treating obesity or metabolic diseases. In one aspect, Gallocatechin Gallate (GCG) and Isoquercitrin (IQC) of the present invention have excellent lipid metabolism control effects, can increase mitochondria in adipocytes, and promote the production of brown fat. Therefore, in one aspect, the present invention can provide a method for preventing, improving, or treating obesity or metabolic diseases.
    Type: Application
    Filed: May 14, 2024
    Publication date: November 28, 2024
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Hyun Woo JEONG, Wanki KIM, Jong Hwa ROH
  • Patent number: 12152650
    Abstract: A medical apparatus according to an example includes: a main body including an inputter configured to receive a user command; a display device positioned to be rotatable on one axis with respect to the main body, and extending along one plane; a locking device limiting a rotation of the display device with respect to the main body when pressure being smaller than first pressure is applied to the display device along a direction that is perpendicular to one surface of the display device; and an attenuator attenuating a vibration of the display device with respect to the main body when pressure being smaller than the first pressure is applied to the display device along the direction that is perpendicular to the one surface of the display device.
    Type: Grant
    Filed: October 6, 2020
    Date of Patent: November 26, 2024
    Assignee: SAMSUNG MEDISON CO., LTD.
    Inventors: Namyun Kim, Simgwan Jeong, Wanki Kim, Kyeonggu Woo, Jinwoo Cha, Wonchul Choi
  • Publication number: 20240350576
    Abstract: The present disclosure relates to a method for lowering blood sugar including administering an effective amount of a green tea peptide composition to a subject in need thereof, and specifically, the green tea peptide composition according to the present disclosure exhibits a blood sugar-lowering effect through excellent stimulation of glucose transport in adipocytes, inhibition of gluconeogenesis in hepatocytes, and DPP-4 inhibitory activity, and can be applied to various health functional food compositions and pharmaceutical compositions.
    Type: Application
    Filed: March 27, 2024
    Publication date: October 24, 2024
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Hyun Woo JEONG, Jinoh Chung, Wanki Kim, Jong Hwa Roh
  • Patent number: 12083822
    Abstract: A medical apparatus according to an embodiment of the present invention includes: a medical device; and a plurality of caster units, disposed below the medical device, for supporting the medical device to be movable, wherein each of the plurality of caster units includes: a wheel part; and a shock absorbing member which is configured to support the wheel part and to absorb the shock applied to the wheel part, wherein the shock absorbing member includes: a wheel fixing member for fixing the wheel part; a body fixing member which surrounds the wheel fixing member and is fixed to the medical device; and a cushioning member which is disposed between the wheel fixing member and the body fixing member and is capable of elastic deformation, wherein the shock absorbing member includes: a first deforming part extending in the vertical direction; and a second deformation part extending, from an end of the first deformation part, in a direction different from the extending direction of the first deformation part.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: September 10, 2024
    Assignee: SAMSUNG MEDISON CO. LTD.
    Inventors: Yoenho Kim, Namyun Kim, Wanki Kim, Sungtae Sim, Junyoung Jung, Wonchul Choi
  • Publication number: 20240226223
    Abstract: The present disclosure relates to a composition for preventing, improving, or treating muscle loss comprising a green tea peptide composition. Specifically, the green tea peptide composition according to the present disclosure may exhibit an efficacy in preventing, improving, or treating muscle loss through the excellent effects of increasing protein synthesis in muscle cells and inhibiting protein degradation in the muscle cells, and thus may be applied in various health functional food compositions and pharmaceutical compositions.
    Type: Application
    Filed: December 12, 2023
    Publication date: July 11, 2024
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Hyun Woo JEONG, Jinoh CHUNG, Wanki KIM, Jong Hwa ROH
  • Publication number: 20240189386
    Abstract: The present disclosure relates to a composition for anti-fatigue comprising a green tea peptide composition. Specifically, the green tea peptide composition according to the present disclosure exhibits anti-fatigue efficacy through excellent effects of inhibiting production of fatigue substances within a muscle cell, increasing ATP production within the muscle cell, and promoting fat oxidation within the muscle cell, and can be applied to various health functional food compositions and pharmaceutical compositions.
    Type: Application
    Filed: November 21, 2023
    Publication date: June 13, 2024
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Hyun Woo JEONG, Jinoh CHUNG, Wanki KIM, Jong Hwa ROH
  • Publication number: 20240196766
    Abstract: An electronic device includes a first electrode, a second electrode, and a memory component configured to store a resistive state. The memory component includes a layered region arranged in direct contact with the first electrode and a bulk region arranged in direct contact with the second electrode. The layered region includes a plurality of first layers made of a first material and a plurality of second layers made of a second material alternatingly arranged with one another. The first material is a phase-change material and the second material is a non-phase-change material. The bulk region is a continuous mass made of a third material that is different than the first material and the second material, and the bulk region is in direct contact with at least two of the first layers and at least one of the second layers of the layered region.
    Type: Application
    Filed: December 8, 2022
    Publication date: June 13, 2024
    Inventors: Matthew Joseph BrightSky, Cheng-Wei Cheng, Guy M. Cohen, Robert L. Bruce, Asit Ray, Wanki Kim
  • Publication number: 20240180993
    Abstract: An aspect of the present disclosure relates to a composition for improving respiratory health exposed to particulate matter, which contains a green tea extract, a green tea polysaccharide and a green tea flavonol as active ingredients. The composition provided in an aspect of the present disclosure can improve respiratory health damaged by exposure to particulate matter by enhancing the effect of preventing adsorption of particulate matter to bronchial epithelial cells and activating the cilia of bronchial epithelial cells. The composition provided in an aspect of the present disclosure may decrease blood heavy metal level.
    Type: Application
    Filed: February 15, 2024
    Publication date: June 6, 2024
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Hyunjin NAM, Juewon KIM, Miyoung PARK, Kyoungmi JUNG, Jinoh CHUNG, Gyeyoung CHOI, Wanki KIM
  • Publication number: 20240181002
    Abstract: The present disclosure relates to a composition for anti-obesity including a green tea peptide composition. Specifically, the green tea peptide composition according to the one aspect of the present disclosure exhibits anti-obesity efficacy through excellent lipid metabolism activation and can be applied to various health functional food compositions and pharmaceutical compositions.
    Type: Application
    Filed: November 21, 2023
    Publication date: June 6, 2024
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Hyun Woo JEONG, Jinoh CHUNG, Wanki KIM, Jong Hwa ROH
  • Patent number: 11968913
    Abstract: A method for fabricating a semiconductor device includes forming air gaps within respective dielectric layer portions to reduce thermal cross-talk between adjacent bits. Each of the dielectric portions is formed on a substrate each adjacent to sidewall liners formed on sidewalls of a phase change memory (PCM) layer. The method further includes forming a pillar including the sidewall liners and the PCM layer, and forming a selector layer on the pillar and the dielectric portions.
    Type: Grant
    Filed: July 28, 2022
    Date of Patent: April 23, 2024
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Wanki Kim, Fabio Carta, Chung H. Lam, Robert L. Bruce
  • Patent number: 11938163
    Abstract: An aspect of the present disclosure relates to a composition for improving respiratory health exposed to particulate matter, which contains a green tea extract, a green tea polysaccharide and a green tea flavonol as active ingredients. The composition provided in an aspect of the present disclosure can improve respiratory health damaged by exposure to particulate matter by enhancing the effect of preventing adsorption of particulate matter to bronchial epithelial cells and activating the cilia of bronchial epithelial cells. The composition provided in an aspect of the present disclosure may decrease blood heavy metal level.
    Type: Grant
    Filed: June 8, 2021
    Date of Patent: March 26, 2024
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Hyunjin Nam, Juewon Kim, Miyoung Park, Kyoungmi Jung, Jinoh Chung, Gyeyoung Choi, Wanki Kim
  • Publication number: 20230381262
    Abstract: A method for reducing absorption of a microplastic in a body, including administering a composition including an effective amount of a green tea extract to a subject in need thereof is disclosed in the specification. One aspect of the present disclosure is the composition may be a food composition or a pharmaceutical composition.
    Type: Application
    Filed: May 30, 2023
    Publication date: November 30, 2023
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Hyun Woo JEONG, Jinoh CHUNG, Wanki KIM, Jong Hwa ROH
  • Publication number: 20230372417
    Abstract: A method for improving hepatic function, including administering an effective amount of a composition including a green tea-derived Lactiplantibacillus plantarum strain; a culture of the strain; a lysate of the strain; an extract of the strain; an extract of the culture; or an extract of the lysate to a subject in need thereof is disclosed in the specification.
    Type: Application
    Filed: May 8, 2023
    Publication date: November 23, 2023
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Hyun Woo JEONG, Donghyun CHO, Wanki KIM, Jong Hwa ROH
  • Patent number: 11717012
    Abstract: The present disclosure relates to an emulsion composition containing ginseng seed oil and ginseng berry extract, wherein the composition is a single phase. Whereas the existing composition containing a water-soluble ingredient as a main ingredient has the problem that, when ginseng seed oil is added, formulation stability is decreased as the ginseng seed oil is separated from the water-soluble ingredient, the emulsion composition according to the present disclosure exhibits superior stability because the ginseng seed oil is uniformly mixed with the water-soluble ingredient and separation of the ginseng seed oil from the water-soluble ingredient does not occur fora long period of time.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: August 8, 2023
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Su Hwan Kim, Sangyoul Na, Hyun Woo Jeong, Wanki Kim, Jisung Kim, Chan Woong Park